Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,203 EUR | +3,34% | +2,30% | +35,28% |
07/05 | Koersdoel AstraZeneca verhoogd; Antofagasta verlaagd | AN |
03/05 | AIB GROUP : Sterkere inkomstengroei en gunstige risicokosten |
Omzet 2024 * | 4,56 mld. 4,94 mld. | Omzet 2025 * | 4,34 mld. 4,7 mld. | Marktkapitalisatie | 12,44 mld. 13,48 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,76 mld. 1,91 mld. | Nettowinst (verlies) 2025 * | 1,56 mld. 1,69 mld. | EV/omzet 2024 * | 2,73 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 2,87 x |
K/w-verhouding 2024 * |
7,17
x | K/w-verhouding 2025 * |
7,46
x | Werknemers | - |
Dividendrendement 2024 * |
5,85% | Dividendrendement 2025 * |
6,2% | Vrij verhandelbaar | 67,6% |
Recentste transcriptie over AIB Group plc
1 week | +2,30% | ||
Lopende maand | +4,59% | ||
1 maand | +1,96% | ||
3 maanden | +24,26% | ||
6 maanden | +21,62% | ||
Lopend jaar | +35,28% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Colin Hunt
CEO | Chief Executive Officer | 54 | 01-01-16 |
Donal Galvin
DFI | Director of Finance/CFO | 50 | 01-09-13 |
Graham Fagan
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Fergal O’Dwyer
BRD | Director/Board Member | 64 | 22-01-21 |
James Pettigrew
CHM | Chairman | 65 | 28-10-21 |
Basil Geoghegan
BRD | Director/Board Member | - | 04-09-19 |
Datum | Koers | Variatie |
---|---|---|
22-05-24 | 5,08 | +0,89% |
21-05-24 | 5,035 | +0,70% |
20-05-24 | 5 | -0,50% |
17-05-24 | 5,025 | +1,15% |
16-05-24 | 4,968 | +0,20% |
uitgestelde koers Börse Stuttgart, 22 mei 2024 om 16:25 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,27% | 573 mld. | |
+17,83% | 310 mld. | |
+24,61% | 258 mld. | |
+23,77% | 214 mld. | |
+26,67% | 190 mld. | |
+32,89% | 174 mld. | |
+9,02% | 331 mld. | |
+8,54% | 150 mld. | |
+8,68% | 136 mld. |